These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38992616)

  • 1. Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia.
    Fifer S; Godsell J; Opat S; Hamad N; Lasica M; Forsyth C; Morand L; Smeaton E; Winton S; Puig A; McGeachie M
    BMC Cancer; 2024 Jul; 24(1):831. PubMed ID: 38992616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient preferences for chronic lymphocytic leukemia treatments: a discrete-choice experiment.
    Ravelo A; Myers K; Brumble R; Bussberg C; Koffman B; Manzoor BS; Biondo JML; Mansfield C
    Future Oncol; 2024; 20(28):2059-2070. PubMed ID: 38861284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Line of therapy and patient preferences regarding lung cancer treatment: a discrete-choice experiment.
    Janse S; Janssen E; Huwig T; Basu Roy U; Ferris A; Presley CJ; Bridges JFP
    Curr Med Res Opin; 2021 Apr; 37(4):643-653. PubMed ID: 33571024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences of patients and physicians in the United States for relapsed/refractory follicular lymphoma treatments.
    Thomas C; Marsh K; Trapali M; Krucien N; Worth G; Cockrum P; Lycett D
    Cancer Med; 2024 Oct; 13(19):e70177. PubMed ID: 39394846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' Preferences for Systemic Lupus Erythematosus Treatments-A Discrete Choice Experiment.
    Collacott H; Phillips-Beyer A; Krucien N; Flamion B; Marsh K
    Patient; 2024 May; 17(3):287-300. PubMed ID: 38270788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient preferences for heart valve disease intervention.
    Fifer S; Keen B; Guilbert-Wright P; Yamabe K; Murdoch DJ
    Health Expect; 2024 Feb; 27(1):e13929. PubMed ID: 38050462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Australian Public Preferences for the Funding of New Health Technologies: A Comparison of Discrete Choice and Profile Case Best-Worst Scaling Methods.
    Whitty JA; Ratcliffe J; Chen G; Scuffham PA
    Med Decis Making; 2014 Jul; 34(5):638-54. PubMed ID: 24713695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment decision-making in chronic lymphocytic leukaemia: Key factors for healthcare professionals. PRELIC study.
    Boqué C; Abad MR; Agustín MJ; García-Goñi M; Moreno C; Gabás-Rivera C; Granados E; Castro-Gómez A; Pardo C; Lizán L
    J Geriatr Oncol; 2020 Jan; 11(1):24-30. PubMed ID: 30954406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Features of Fertility Treatment do Patients Value? Price Elasticity and Willingness-to-Pay Values from a Discrete Choice Experiment.
    Keller E; Botha W; Chambers GM
    Appl Health Econ Health Policy; 2023 Jan; 21(1):91-107. PubMed ID: 36171511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study.
    Sportoletti P; Laurenti L; Chiarenza A; Gaidano G; Albi E; Mauro FR; Trentin L; Vallisa D; Pane F; Cuneo A; Albano F; Zamprogna G; Coscia M; Gozzetti A; Reda G; Caira M; Finsinger P; Gualberti G; Iannella E; Malgieri S; Molica S
    Hematol Oncol; 2024 Jan; 42(1):e3216. PubMed ID: 37772620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alignment of preferences in the treatment of multiple myeloma - a discrete choice experiment of patient, carer, physician, and nurse preferences.
    Fifer SJ; Ho KA; Lybrand S; Axford LJ; Roach S
    BMC Cancer; 2020 Jun; 20(1):546. PubMed ID: 32527324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' priorities in selecting chronic lymphocytic leukemia treatments.
    Mansfield C; Masaquel A; Sutphin J; Weiss E; Gutierrez M; Wilson J; Boeri M; Li J; Reyes C
    Blood Adv; 2017 Nov; 1(24):2176-2185. PubMed ID: 29296865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment.
    Turk D; Boeri M; Abraham L; Atkinson J; Bushmakin AG; Cappelleri JC; Hauber B; Klein K; Russo L; Viktrup L; Walsh D
    Osteoarthritis Cartilage; 2020 Sep; 28(9):1202-1213. PubMed ID: 32652238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the Self-Reported Acceptability of Discrete Choice Experiment and Best-Worst Scaling: An Empirical Study in Patients with Type 2 Diabetes Mellitus.
    Li F; Liu S; Gu Y; Li S; Tao Y; Wei Y; Chen Y
    Patient Prefer Adherence; 2024; 18():1803-1813. PubMed ID: 39229369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug development.
    Seo J; Smith BD; Estey E; Voyard E; O' Donoghue B; Bridges JFP
    Curr Med Res Opin; 2018 Dec; 34(12):2031-2039. PubMed ID: 29565196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Older adult patient preferences for the content and format of prescription medication labels - A best-worst scaling and discrete choice experiment study.
    Malhotra R; Suppiah SD; Tan YW; Sung P; Tay SSC; Tan NC; Koh GC; Chan A; Chew LST; Ozdemir S;
    Res Social Adm Pharm; 2023 Nov; 19(11):1455-1464. PubMed ID: 37507340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Treatment Preferences Among People Living with HIV in Australia: A Discrete Choice Experiment.
    Fifer S; Kularatne T; Tan M; Drummond F; Rule J
    Patient Prefer Adherence; 2023; 17():1825-1843. PubMed ID: 37525842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative importance of clinical outcomes and safety risks of antiseizure medication monotherapy for patients and physicians: Discrete choice experiment eliciting preferences in real-world study "VOTE".
    Rosenow F; Winter Y; Leunikava I; Brunnert M; Joeres L; Sutphin J; Boeri M; Smith J; Villani F; Brandt C
    Epilepsia; 2022 Feb; 63(2):451-462. PubMed ID: 34921391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valuing injection frequency and other attributes of type 2 diabetes treatments in Australia: a discrete choice experiment.
    Fifer S; Rose J; Hamrosi KK; Swain D
    BMC Health Serv Res; 2018 Aug; 18(1):675. PubMed ID: 30165844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.